Zamanian-Daryoush’s study [33] on the murine malignant melanoma model revealed that, compared to apoA1-deficient mice, human apoA1 transgene mice exhibited reduced tumor burden, decreased metastasis, and enhanced survival, which was associated with the increased infiltration of M1 macrophages. The gene discussed is APOA1; the disease is melanoma.